Comparative study of therapeutic effects according to duration of medium-dose aspirin therapy at the acute stage of Kawasaki disease |
Lee, Jung Hwa
(Department of Pediatrics, School of Medicine, Konkuk University)
Lee, So Hee (Department of Pediatrics, School of Medicine, Konkuk University) Lee, Sang Taek (Department of Pediatrics, School of Medicine, Konkuk University) Park, Yong Hyun (Department of Nursing, Chungju Hospital, Konkuk University) Hong, Seong Jin (Department of Pediatrics, School of Medicine, Konkuk University) |
1 | Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and longterm management of Kawasaki disease : A statement for health professionals from the committee on rheumatic fever, endocarditis and Kawasaki disease, Council on cardiovascular disease in the young, American Heart Association. Circulation 2004;110:2747-71 DOI ScienceOn |
2 | Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo, Japan. Ministry of Health and Welfare. 1984 |
3 | Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y Kazue T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85 DOI ScienceOn |
4 | Koren G, Rose V, Lavi S, Rowe R. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease. JAMA 1985;254:767-9 DOI |
5 | Ichida F, Fatica NS, Engle MA, O'Loughlin JE, Klein AA, Snyder MS, et al. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York : risk factors and role of aspirin. Pediatrics 1987;80:828-35 |
6 | Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin but independent of salicylate dose. J Pediatr 1997;131:888-93 DOI ScienceOn |
7 | Saulsbury FT. Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome. Clin Pediatr 2002;41:597-601 DOI |
8 | Matsubara T, Mason W, Kashini IA. Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease. J Pediatr 1996;128:701-3 DOI ScienceOn |
9 | Kato H, Koike S, Yokoyama T. Kawasaki disease : effect of treatment on coronary artery involvement. Pediatrics 1979; 63:175-9 |
10 | Lee JH, Hung HY, Huang FY. Kawasaki disease and Reye syndrome : report of one case. Acta Paed Sin 1992;33:67-71 |
11 | Akagi T, Kato H, Inoue O, Sato N. Salicylate treatment in Kawasaki disease : High dose or low dose? Eur J Pediatr 1991;150:642-6 DOI |
12 | Melish ME. Comparison of low-dose aspirin vs. high dose aspirin as an adjunct to intravenous gamma globulin in the treatment of Kawasaki syndrome. Pediatr Res 1992;31:170A DOI ScienceOn |
13 | Furusho K, Sato K, Soeda T, Matsumoto H, Hirota T, Kawada S. High-dose intraveous gammaglobulin for Kawasaki disease. Lancet 1983;10:1359 |
14 | Hanley SP, Bevan J, Cockbill SR, Heptinstall S. Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet 1981;2:969-71 |
15 | Kusakawa S, Tatara K. Efficacies and risks of aspirin in the treatment of Kawasaki disease. Prog Clin Biol Resear 1987;250:401-13 |
16 | Jacobs JC. Successful treatment of Kawasaki disease with high dose aspirin. Pediatr Res 1978;12:494 |
17 | Harada K. Intravenous gammaglobulin treatment in Kawasaki disease. Acta Paediatr Jpn 1991;33:805-10 DOI |
18 | Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Haung SM. Treatment of acute Kawasaki disease : Aspirin's role in the febrile stage revisited. Pediatrics 2004;114:689-93 DOI ScienceOn |
19 | Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease : a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96:1057-61 |
20 | Koren G, Schaffer F, Silverman E. Determinant of low serum concentrations of salicylate in patient with Kawasaki disease. J Pediatr 1988;112:663-7 DOI |
21 | Mulberg AE, Verhave M. Identification and treatment of nonsteroidal anti-inflammatory drug-induced gastroduodenal injury in children. Am J Dis Child 1993;147:1280-1 |
22 | Shulman ST, Rowley SH. Advances in Kawasaki disease. Eur J Pediatr 2004;163:285-91 DOI ScienceOn |
23 | Moran AM, Newburger JW, Sanders SP, Parness IA, Spevak PJ, Burns JC, et al. Abnormal myocardial mechanics in Kawasaki disease : rapid response to gamma-globulin. Am Heart J 2000;139:217-23 |